Trump unveils plan to slash drug costs tied to what’s paid abroad
The pharmaceutical industry and many conservative groups vehemently oppose the most favored nations plan.
The pharmaceutical industry and many conservative groups vehemently oppose the most favored nations plan.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
While three vaccine developers have entered the final stages of trials, phase III, the studies take months and enroll tens of thousands of people.
Some drugmakers have delayed or staggered increases amid increased scrutiny and the fear of catching President Donald Trump’s eye.
Some drugmakers have delayed or staggered increases amid increased scrutiny and the fear of catching President Donald Trump’s eye.
Senators questioned top Trump public health officials at a Thursday hearing on vaccine pricing.
Senators questioned top Trump public health officials at a Thursday hearing on vaccine pricing.
Federal officials may defer to the National Academy of Medicine.
Senators questioned top Trump public health officials at a Thursday hearing on vaccine pricing.
Federal officials may defer to the National Academy of Medicine.
Senators questioned top Trump public health officials at a Thursday hearing on vaccine pricing.
Federal officials may defer to the National Academy of Medicine.
The agency also left open the possibility it would issue an emergency use authorization for a vaccine.
The agency also left open the possibility it would issue an emergency use authorization for a vaccine.
The drug would be the first known to reduce deaths in Covid-19 patients.
The drug would be the first known to reduce deaths in Covid-19 patients.
The drug would be the first known to reduce deaths in Covid-19 patients.
The agency now believes that the suggested dosing regimens “are unlikely to produce an antiviral effect,” FDA chief scientist Denise Hinton said in a letter.
The agency now believes that the suggested dosing regimens “are unlikely to produce an antiviral effect,” FDA chief scientist Denise Hinton said in a letter.
Drugmakers and health agencies have already begun rewriting the rules of vaccine research.
The drug would be the first known to reduce deaths in Covid-19 patients.
The agency now believes that the suggested dosing regimens “are unlikely to produce an antiviral effect,” FDA chief scientist Denise Hinton said in a letter.
Drugmakers and health agencies have already begun rewriting the rules of vaccine research.
The agency now believes that the suggested dosing regimens “are unlikely to produce an antiviral effect,” FDA chief scientist Denise Hinton said in a letter.